Literature DB >> 17701270

Non-excision treatment of multiple cutaneous neurofibromas by laser photocoagulation.

Tarek F Elwakil1, Nevien A Samy, Mahmoud S Elbasiouny.   

Abstract

Neurofibromatosis type 1 (NF-1) is an autosomal dominant disorder characterized by skin tumours derived from peripheral nerves. It is a clinically diagnosed disorder of a mainly cosmetic concern. There are different excision modalities for treatment of cutaneous neurofibromas; however, none is considered to be universally accepted treatment. This study was conducted to evaluate a non-excision treatment of multiple cutaneous neurofibromas, using surface and interstitial approaches of neodymium:yttrium aluminum garnet (Nd:YAG) laser (1,064 nm) photocoagulation, depending upon the size and location of the lesions. Twelve patients with multiple cutaneous neurofibromas were included. Surface laser photocoagulation by long-pulsed Nd:YAG laser has been used for treatment of flat lesions, while interstitial laser photocoagulation by continuous wave (CW) Nd:YAG laser has been used for treatment of bulkier lesions. After 14 months of follow up, both approaches of laser photocoagulation have shown different success rates, as denoted by the regression of the lesions, an overall acceptable cosmetic outcome, and, generally, patients' satisfaction. Within the limitations of the present study, laser photocoagulation has proven to be a promising technique that may be an alternative or additive modality for treatment of multiple cutaneous neurofibromas. It is a minimally invasive, office-based technique that could be used safely and effectively, with a limited rate of complications. Surface laser photocoagulation has proven to be an effective tool for treatment of flat lesions, especially those located in exposed areas, with a favourable cosmetic result, while interstitial laser photocoagulation could be reserved for bulkier lesions, especially those located in non-exposed areas. However, further studies are necessary to refine the procedure, and to confirm the present encouraging findings, especially over a longer period of follow up, as well as to evaluate laser parameters for optimization of the technique.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17701270     DOI: 10.1007/s10103-007-0485-3

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  12 in total

1.  Cold air in laser therapy: first experiences with a new cooling system.

Authors:  C Raulin; B Greve; S Hammes
Journal:  Lasers Surg Med       Date:  2000       Impact factor: 4.025

Review 2.  The genetic and molecular pathogenesis of NF1 and NF2.

Authors:  Kaleb H Yohay
Journal:  Semin Pediatr Neurol       Date:  2006-03       Impact factor: 1.636

3.  Laser surgery of Neurofibromatosis 1 (NF 1).

Authors:  D Katalinic
Journal:  J Clin Laser Med Surg       Date:  1992-06

4.  Coagulation and temperature distribution in Nd: YAG interstitial laser thermotherapy: an in vitro animal study.

Authors:  B M Lippert; A Teymoortash; B J Folz; J A Werner
Journal:  Lasers Med Sci       Date:  2003       Impact factor: 3.161

5.  Prognostic signs in the surgical management of plexiform neurofibroma: the Children's Hospital of Philadelphia experience, 1974-1994.

Authors:  M N Needle; A Cnaan; J Dattilo; J Chatten; P C Phillips; S Shochat; L N Sutton; S N Vaughan; E H Zackai; H Zhao; P T Molloy
Journal:  J Pediatr       Date:  1997-11       Impact factor: 4.406

Review 6.  Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective.

Authors:  Ronnie Tung-Ping Poon; Sheung-Tat Fan; Flora Hau-Fung Tsang; John Wong
Journal:  Ann Surg       Date:  2002-04       Impact factor: 12.969

7.  CO2 laser treatment of cutaneous neurofibromas.

Authors:  R K Roenigk; J L Ratz
Journal:  J Dermatol Surg Oncol       Date:  1987-02

8.  Effect of ultrasound-guided interstitial laser photocoagulation on benign solitary solid cold thyroid nodules - a randomised study.

Authors:  Helle Døssing; Finn Noe Bennedbaek; Laszlo Hegedüs
Journal:  Eur J Endocrinol       Date:  2005-03       Impact factor: 6.664

9.  Use of the carbon dioxide laser in treating multiple cutaneous neurofibromas.

Authors:  D W Becker
Journal:  Ann Plast Surg       Date:  1991-06       Impact factor: 1.539

Review 10.  Neurofibromatosis type 1: new insights into neurocognitive issues.

Authors:  Maria T Acosta; Gerard A Gioia; Alcino J Silva
Journal:  Curr Neurol Neurosci Rep       Date:  2006-03       Impact factor: 5.081

View more
  5 in total

1.  A patient with loss of vision in the right eye and neurofibromatosis type 1.

Authors:  Nicola Mumoli; Marco Cei; Carlo Bartolomei; Vania Pirillo
Journal:  CMAJ       Date:  2009-01-20       Impact factor: 8.262

2.  Neurofibromatosis Type 1: Review of Cutaneous and Subcutaneous Tumor Treatment on Quality of Life.

Authors:  Lawrence A Taylor; Victor L Lewis
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-01-18

3.  Care of adults with neurofibromatosis type 1: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).

Authors:  Douglas R Stewart; Bruce R Korf; Katherine L Nathanson; David A Stevenson; Kaleb Yohay
Journal:  Genet Med       Date:  2018-04-26       Impact factor: 8.822

4.  Status and Recommendations for Incorporating Biomarkers for Cutaneous Neurofibromas Into Clinical Research.

Authors:  Deeann Wallis; Anat Stemmer-Rachamimov; Sarah Adsit; Bruce Korf; Dominique Pichard; Jaishri Blakeley; Kavita Y Sarin
Journal:  Neurology       Date:  2021-07-06       Impact factor: 11.800

5.  Cutaneous neurofibromas in Neurofibromatosis type I: a quantitative natural history study.

Authors:  Ashley Cannon; Mei-Jan Chen; Peng Li; Kevin P Boyd; Amy Theos; David T Redden; Bruce Korf
Journal:  Orphanet J Rare Dis       Date:  2018-02-07       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.